NHS not ready for groundbreaking Alzheimer’s drugs, warns charity
4 hours ago About sharing By Fergus Walsh Medical editor Alzheimer’s patients could lose out on two groundbreaking new drugs because the NHS is unprepared, a leading charity has told BBC Panorama. Lecanemab and donanemab slow down the early stages of the disease – which is the most common form of dementia. But Alzheimer’s Research…